1-(2-MORPHOLIN-4-YLETHYL)-1H-BENZIMIDAZOL-2-AMINE
- $318 - $796.95
- Product name: 1-(2-MORPHOLIN-4-YLETHYL)-1H-BENZIMIDAZOL-2-AMINE
- CAS: 26840-48-2
- MF: C13H18N4O
- MW: 246.31
- EINECS:
- MDL Number:MFCD00181090
- Synonyms:ART-CHEM-BB B000443;1-(2-morpholin-4-ylethyl)benzimidazol-2-amine;1-(2-morpholinoethyl)-2-benzimidazolamine;1-(2-morpholinoethyl)benzimidazol-2-amine;1-[2-(4-Morpholinyl)ethyl]-1H-benzimidazol-2-ylamine;AKOS B000443;1-(2-MORPHOLIN-4-YLETHYL)-1H-BENZIMIDAZOL-2-AMINE;1-(2-Morpholin-4-ylethyl)-1H-benzoimidazol-2-amine
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0082409
- Product description1-(2-MORPHOLIN-4-YL-ETHYL)-1H-BENZOIMIDAZOL-2-YLAMINE 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11155933
- Product description1-(2-Morpholinoethyl)-1H-benzo[d]imidazol-2-amine 97%
- Packaging1g
- Price$318
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number032686
- Product description1-(2-Morpholin-4-yl-ethyl)-1H-benzoimidazol-2-ylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0082409 | 1-(2-MORPHOLIN-4-YL-ETHYL)-1H-BENZOIMIDAZOL-2-YLAMINE 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
Crysdot | CD11155933 | 1-(2-Morpholinoethyl)-1H-benzo[d]imidazol-2-amine 97% | 1g | $318 | 2021-12-16 | Buy |
Matrix Scientific | 032686 | 1-(2-Morpholin-4-yl-ethyl)-1H-benzoimidazol-2-ylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|